Vitamin D in Nephrotic Syndrome in Childre
Phase 3
- Conditions
- ephrotic Syndrome.Nephrotic syndrome
- Registration Number
- IRCT20130518013366N11
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Affected to Nephrotic Syndrome
Exclusion Criteria
Patients who were not available during the next year and can not go to the center for follow-up treatment
Patients with other underlying illnesses
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Signs of Nephrotic Syndrome. Timepoint: Before treatment and 2 months after the administration of vitamin D. Method of measurement: Urine and blood test and clinical examination.
- Secondary Outcome Measures
Name Time Method